Humanized Mouse and Rat Model Market Size, Share, Growth, Forecast 2030

Humanized Mouse and Rat Model Market: Overview

The report covers forecasts and analysis for the humanized mouse and rat model market on a global and regional level. The study provides historic data from 2016 along with forecasts from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the humanized mouse and rat model market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the humanized mouse and rat model market on a global as well as regional level.

In order to give the users of this report a comprehensive view of the humanized mouse and rat model market, we have included a competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness.

Humanized Mouse and Rat Model Market: Overview

The report provides a company market share analysis in order to give a broader overview of the key players in the humanized mouse and rat model market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new type launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the humanized mouse and rat model market on a global and regional basis.

The study provides a crucial view of the humanized mouse and rat model by segmenting the market based on type, application, end-user, and region. All the segments of humanized mouse and rat model market have been analyzed based on present and future trends and the market is estimated from 2018 to 2025.

A humanized mouse refers to a mouse with functioning human tissues, cells, genes, and/or organs. These humanized mice are useful for biological and medical research as small animal models for human therapeutics. Also, these can be used as models to study the human immune system to mimic pathological conditions and may facilitate therapeutic drug candidate evaluation in vitro.

The demand for humanized mouse and rat model market is driven by increasing humanized model-based research and development activities for various therapeutic applications such as cancer, autoimmune and immunodeficiency disorders, rare genetic disorders, etc. along with a rising preference for personalized medicine, continuous funding from the government to support research and growing collaborations between academic institutes and industries. However, the high cost of development, strict ethical regulations on animal welfare, and time intensive development process are major factors that may impede the market growth. With increasing monoclonal antibody production, emerging markets are expected to bring new growth avenues for major players in humanized mouse and rat models.

Based on type, the global humanized mouse and rat model market is bifurcated into humanized rat models and humanized mouse models. The humanized mouse models segment accounted for the largest market share in 2018 whereas humanized rat models segment is expected to grow at the highest CAGR over the forecast period. The humanized mouse model type segment is further split into cell based humanized mouse models and genetic humanized mouse models. The key factors for the growth of humanized mouse models are increasing biotechnology and pharmaceutical research and development activities, increasing investment in research on the development of humanized models along with increasing demand for personalized medicines.

Humanized Mouse and Rat Model Market: Report Scope

Based on applications market is segmented into hematopoiesis, toxicology, neuroscience, immunology and infectious diseases, oncology, and other applications. The oncology application segment is projected to witness the highest growth rate over the forecast period owing to the increasing prevalence of cancer across the globe and the rise in the fund to support research studies on cancer.

The end user segment of the humanized mouse and rat model market is divided into academic & research institutes, contract research organizations (CROs), and pharmaceutical & biotechnological companies. The largest end users for the global humanized mouse and rat model market were pharmaceutical & biotechnological companies in 2018. Contract research organizations are projected to witness rapid growth in the coming years. The growing preference for outsourcing studies is expected to boost the demand for CROs.

Humanized Mouse and Rat Model Market: Competitive Analysis

Major players in humanized rat models are Yecuris Corporation, Hera BioLabs, and Horizon Discovery Group plc. Major players in humanized mouse models are Champions Oncology, Inc., Transgenic, Inc., Crown Bioscience, Inc., AXENIS S.A.S, inGenious Targeting Laboratory, Vitalstar Biotechnology Co., Ltd., Hera BioLabs, Harbour Antibodies BV, Charles River Laboratories, genOway, S.A., Horizon Discovery Group plc, Taconic Biosciences, Inc., and The Jackson Laboratory among others.

Humanized Mouse and Rat Model Market: Regional Analysis

North America dominated the global humanized mouse and rat model market in 2018. Increasing focus to develop humanized mouse and rat models for various therapeutic applications, increasing investment for research on humanized models, increasing demand for personalized medicine, presence of major market players, and presence of developed infrastructure are the factors attributing to the growth in this region. Europe was the second largest market in terms of revenue share. The availability of research funds, increasing R&D spending for the development of personalized medicine, and the presence of developed infrastructure are factors that boost the market growth in this region. Asia Pacific region will be the rapidly growing market for humanized mouse and rat models.

Request Free Sample

The growing focus of contract research organizations on business expansion in emerging markets like China and India, the focus of pharmaceutical companies on reducing the drug approval time, and growth in the pharmaceutical and biopharmaceutical industry in Asia, are factors that are expected to propel market growth in the Asia Pacific. The Middle East and Africa will register slower growth compared to other regions. On the other hand, Latin America will exhibit moderate growth in the coming years.

The report segment of global humanized mouse and rat model market as follows:

Global Humanized Mouse and Rat Model Market: Type

• Humanized Mouse Models
  • Genetic Humanized Mouse Models
  • Cell-based Humanized Mouse Models
• Humanized Rat Model

Global Humanized Mouse and Rat Model Market: By Application

• Oncology
• Immunology and Infectious Diseases
• Neuroscience
• Toxicology
• Hematopoiesis
• Other Applications

Global Humanized Mouse and Rat Model Market: By End User

• Pharmaceutical & Biotechnological Companies
• Academic & Research Institutes
• Contract Research Organizations (CROs)

Global Humanized Mouse and Rat Model Market: By Region

• North America
  • U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• The Middle East and Africa